Intracranial Aneurysm Market | USD 3,307.69 Million by 2034
The intracranial aneurysm market size was exhibited at USD 1,380.65 million in 2024 and is projected to hit around USD 3,307.69 million by 2034, growing at a CAGR of 9.13% during the forecast period 2024 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 1,506.70 Million |
| Market Size by 2034 | USD 3,307.69 Million |
| Growth Rate From 2024 to 2034 | CAGR of 9.13% |
| Base Year | 2024 |
| Forecast Period | 2024-2034 |
| Segments Covered | Type, End-use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Covered | North America, Europe, Asia Pacific, Latin America, MEA |
| Key Companies Profiled | Medtronic; Stryker; MicroPort Scientific Corporation.; Johnson & Johnson Services, Inc.; MicroVention Inc.; B. Braun Melsungen AG; Integra LifeSciences; RAUMEDIC AG; Terumo Corporation; Delta Surgical |
Increasing incidence of neurological diseases is a major factor contributing to the market growth. According to the World Federation of Neurology article report published in October 2024, neurological disorders rank as the second leading cause of death and the primary cause of global disability.
A recent Global Burden of Disease study predicts a doubling of individuals affected by brain diseases by 2050, with about 40% of the current global population already impacted. Technological advancements and increasing preference for targeted therapy approach are factors expected to drive the market growth in the forecast period.
The prevalence of a variety of health disorders, including brain aneurysms, increases as the world's population ages. Elderly individuals are more likely to develop aneurysms, especially in the brain. For instance, as per the reports published by University Of Minnesota in March 2024, the Brain Aneurysm Foundation states that 1 in 50 Americans or approximately 6.7 million people-have an unruptured brain aneurysm. Annually, about 30,000 individuals in the nation experience the rupture of a brain aneurysm, translating to roughly one rupture occurring every 18 minutes.
The market is also driven significantly due to technological advancements. According to an article published by IntechOpen in February 2024, unruptured intracranial aneurysms (IAs) pose a significant public health concern, affecting 3-7% of the population. Neuroimaging breakthroughs, including magnetic resonance angiography (MRA), computed tomographic angiography (CTA), and digital subtraction angiography (DSA), have led to increased detection of aneurysms. Researchers are focusing on identifying risk factors and developing prediction models for various stages of aneurysm development, including initiation, growth, rupture, and intervention assessment. Noteworthy scoring systems like PHASES for rupture risk and ELAPSS for growth risk have been developed. However, these existing models primarily predict gap events and lack a comprehensive range of objective predictive analytics essential for shared decision-making.
The growing incidence of individuals experiencing higher blood pressure and damage to blood vessels serves as a significant catalyst for the expansion of the market. According to the WHO article published in September 2024, The report showed that about four out of five people with high blood pressure do not receive appropriate treatment. But if countries expand insurance coverage, 76 million deaths are expected to avoid between 2024 and 2050. 1 in 3 adults worldwide has high blood pressure issues. An estimated 1.28 billion adults aged 30 to 79 worldwide have high blood pressure, most of whom (two-thirds) live in low- and middle-income countries.This escalating trend in patients dealing with high blood pressure and vascular trauma influences an increased demand for interventions and treatments related to intracranial aneurysms.
Based on type, the endovascular coiling segment led the market with the largest revenue share of 84.6% in 2024, the endovascular coiling technique is a minimally invasive procedure that employs a catheter to identify and treat aneurysms in the brain. This method involves navigating a catheter from the groin area through the artery leading to the aneurysm. Once positioned, embolic coils or liquids are introduced through the catheter to induce embolization, effectively preventing blood flow into the aneurysm. The advancements in the products designed for the treatments of neurological disorders developed by the industry key players drive the market's growth. For instance, in January 2024, is the IMPASS embolic coil device, this innovative device is designed for the treatment of Chronic Subdural Hematomas (CSDH), a condition affecting the outermost layer of the brain. Especially, the device has demonstrated successful application in in-vivo studies, specifically in the embolization of the middle meningeal artery (MMA). Fluidx Medical Technology, Inc. publicly disclosed this significant development, highlighting the role of technological innovation in driving progress within the field of neurological disorder treatments.
The flow diverters segment is anticipated to witness fastest CAGR over the forecast period. Continuous evolution of flow diverter technology boosts market growth. According to the SAGE Publications article published in October 2024, recent advancements involve surface modifications with various compounds to enhance blood compatibility, reducing the risk of clotting and thrombosis. These modifications aim to streamline deployment and, crucially, cover how to use a single antiplatelet therapy, eliminating the need for Dual Antiplatelet Therapy (DAPT). This innovation potentially expands the applications of flow diverters to include ruptured intracranial aneurysms, presenting a significant advancement in treatment options. Moreover, for instance, in June 2022, Stryker and Carmeda partnered to enhance the treatment of brain aneurysms. The collaboration integrates Stryker's established flow diverter technology with Carmeda's active heparin coatings. Stryker's flow diverter, utilizing Carmeda's covering, demonstrates a significant reduction in thrombin, a potent platelet agonist, and coagulation factor.
Based on end-use, the hospital segment led the market in 2024 with the largest revenue share of 90.0%. This is attributed to the use of technologically advanced equipment in operation theaters and intensive care units, the increasing number of hospitals worldwide, and rising government funding for the hospitals. Technologically advanced devices are being used extensively in hospitals to provide better treatment. These devices are not only simplifying treatment procedures but are also helping provide better, faster, and more accurate results.
The clinic segment is also anticipated to witness a significant CAGR over the forecast period. Intracranial aneurysm procedures are among the most critical and complicated surgeries that are dependent on high-quality and durable equipment, which are used in hospitals. Hospitals are also better equipped to handle any post-operative complications and they include facilities for physical rehabilitation post surgeries. Also, hospitals are widely preferred by patients in comparison to emergency clinics owing to better healthcare facilities and the availability of advanced equipment. Thus, these factors are significantly boosting the segment growth.
North America dominated the market with the revenue share of 26.65% in 2024 owing to the presence of well-established healthcare infrastructure, the rising geriatric population, and the high incidence of hypertension and stroke. In addition, the increasing occurrence of intracranial aneurysms and the escalating demand for minimally invasive surgeries are driving the market growth in this region. Moreover, numerous initiatives being taken by different organizations are expected to boost market growth. For example, The Bee Foundation (TBF), a non-profit entity, is dedicated to raising awareness and decreasing the mortality rates associated with cerebral aneurysms via pioneering research.
The Asia Pacific market is anticipated to witness the fastest CAGR over the forecast period. This is attributed to factors, such as the growing aging population, high lifestyle stress, rising incidence of hypertension, improvement in the quality of diagnosis, and increasing patient affordability. These factors have together resulted in a considerable number of intracranial aneurysm procedures in Asia Pacific. Furthermore, the potential for expansion in emerging markets like Brazil, India, and China could further boost regional market growth. For example, the growing trend of medical tourism in India due to the lower costs of intracranial surgeries compared to developed nations like the U.S. is anticipated to stimulate market growth. Specifically, the cost of aneurysm surgery in India averages around USD 7,000, in contrast to the USD 30,000 charged in the U.S.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the intracranial aneurysm market
Type
End-use
Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers